Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Sarepta Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Sarepta Therapeutics Inc. June 4, 202684.2%
-
Sarepta Therapeutics Inc. June 6, 202485.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 4, 2026 | Sarepta Therapeutics Inc. | Grant or award | +16,875 | — | — |
| Mar 10, 2025 | Sarepta Therapeutics Inc. | Grant or award | +2,383 | — | — |
| Dec 12, 2024 | Sarepta Therapeutics Inc. | Option exercise | +10,500 | $13.71 | $143,955 |
| Dec 12, 2024 | Sarepta Therapeutics Inc. | Open-market sale | −10,500 | $124.84 | $1,310,820 |
| Mar 8, 2024 | Sarepta Therapeutics Inc. | Option exercise | +15,000 | $13.90 | $208,500 |
| Mar 8, 2024 | Sarepta Therapeutics Inc. | Open-market sale | −3,155 | $123.85 | $390,747 |
| Mar 8, 2024 | Sarepta Therapeutics Inc. | Open-market sale | −11,745 | $123.10 | $1,445,810 |
| Mar 8, 2024 | Sarepta Therapeutics Inc. | Open-market sale | −100 | $122.39 | $12,239 |
| Mar 1, 2024 | Sarepta Therapeutics Inc. | Grant or award | +1,846 | — | — |
| Aug 4, 2023 | Sarepta Therapeutics Inc. | Option exercise | +15,000 | $29.03 | $435,450 |
| Aug 4, 2023 | Sarepta Therapeutics Inc. | Open-market sale | −15,000 | $106.72 | $1,600,800 |
| Mar 6, 2023 | Sarepta Therapeutics Inc. | Grant or award | +1,523 | — | — |
Questions about Hans Lennart Rudolf Wigzell
What boards is Hans Lennart Rudolf Wigzell on?
Hans Lennart Rudolf Wigzell sits on the board of Sarepta Therapeutics Inc.
How long has Hans Lennart Rudolf Wigzell served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.